H&P/Triad Stops OTC Manufacturing In Consent Decree With FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA forbids Triad Group, H&P Industries and three employees from manufacturing or distributing OTC products until they comply with good manufacturing practices.
You may also be interested in...
People In Brief
CHPA scientists Schneider, Roehrig exit
People In Brief
CHPA scientists Schneider, Roehrig exit
People In Brief
CHPA scientists Schneider, Roehrig exit